DE69017825T2 - Heilverfahren von Lebererkrankungen mit Verwendung von Pyrrol-Chinolin-Chinone-Triester und neue Pyrrol-Chinolin-Chinone-Triester. - Google Patents

Heilverfahren von Lebererkrankungen mit Verwendung von Pyrrol-Chinolin-Chinone-Triester und neue Pyrrol-Chinolin-Chinone-Triester.

Info

Publication number
DE69017825T2
DE69017825T2 DE69017825T DE69017825T DE69017825T2 DE 69017825 T2 DE69017825 T2 DE 69017825T2 DE 69017825 T DE69017825 T DE 69017825T DE 69017825 T DE69017825 T DE 69017825T DE 69017825 T2 DE69017825 T2 DE 69017825T2
Authority
DE
Germany
Prior art keywords
triesters
quinone
quinoline
pyrrole
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69017825T
Other languages
English (en)
Other versions
DE69017825D1 (de
Inventor
Teizi Urakami
Mitsunori Oda
Chieko Itoh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Gas Chemical Co Inc
Original Assignee
Mitsubishi Gas Chemical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP26210989A external-priority patent/JPH03123781A/ja
Priority claimed from JP16848490A external-priority patent/JPH0459729A/ja
Application filed by Mitsubishi Gas Chemical Co Inc filed Critical Mitsubishi Gas Chemical Co Inc
Publication of DE69017825D1 publication Critical patent/DE69017825D1/de
Application granted granted Critical
Publication of DE69017825T2 publication Critical patent/DE69017825T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69017825T 1989-10-09 1990-10-08 Heilverfahren von Lebererkrankungen mit Verwendung von Pyrrol-Chinolin-Chinone-Triester und neue Pyrrol-Chinolin-Chinone-Triester. Expired - Fee Related DE69017825T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26210989A JPH03123781A (ja) 1989-10-09 1989-10-09 ピロロキノリンキノンエステル
JP16848490A JPH0459729A (ja) 1990-06-28 1990-06-28 肝障害抑制剤

Publications (2)

Publication Number Publication Date
DE69017825D1 DE69017825D1 (de) 1995-04-20
DE69017825T2 true DE69017825T2 (de) 1995-07-13

Family

ID=26492174

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69017825T Expired - Fee Related DE69017825T2 (de) 1989-10-09 1990-10-08 Heilverfahren von Lebererkrankungen mit Verwendung von Pyrrol-Chinolin-Chinone-Triester und neue Pyrrol-Chinolin-Chinone-Triester.

Country Status (3)

Country Link
US (1) US5061711A (de)
EP (1) EP0423012B1 (de)
DE (1) DE69017825T2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69131123T2 (de) * 1990-01-11 1999-09-30 Upjohn Co 6,7,8,9-tetrahydro-3h-benz(e)indolheterocyclen mit wirkung auf das zentrale nervensystem
US5369112A (en) * 1991-03-04 1994-11-29 Mitsubishi Gas Chemical Company, Inc. Method of treating cataracts caused by active oxygen
US5460819A (en) * 1991-12-13 1995-10-24 Children's Medical Center Corporation Method for treating PQQ-responsive heavy metal toxicity
DE69313316T2 (de) * 1992-02-07 1998-02-19 Mitsubishi Gas Chemical Co Verwendung von Oxazopyrrolochinolinen und Pyrrolochinolonchinonen zur Herstellung von Produktionsbeschleunigern von Nervenwachstumsfaktoren g
US5616576A (en) * 1994-07-12 1997-04-01 The Children's Medical Center Corporation Controlling bone resorption with pyrroloquinoline quinone (PQQ) and related compounds
US20070264200A1 (en) * 2005-11-14 2007-11-15 Scott Small Mouse MRI for drug screening
JP5240362B2 (ja) 2009-07-16 2013-07-17 三菱瓦斯化学株式会社 ピロロキノリンキノンのナトリウム塩結晶

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1302275C (en) * 1986-08-07 1992-06-02 Yuji Narutomi Enzyme inhibitor
JPS63192717A (ja) * 1987-02-06 1988-08-10 Ube Ind Ltd 肝臓疾患用剤

Also Published As

Publication number Publication date
US5061711A (en) 1991-10-29
EP0423012B1 (de) 1995-03-15
DE69017825D1 (de) 1995-04-20
EP0423012A3 (en) 1992-03-04
EP0423012A2 (de) 1991-04-17

Similar Documents

Publication Publication Date Title
DE69008664D1 (de) Bestrahlung von bluterzeugnissen.
DE68920775T2 (de) Behandlung von faserigen Materialien.
ATE112963T1 (de) Gewebeentzusammensetzung und verfahren.
DE69434223D1 (de) In der behandlung von il4 auslösenden krankheiten nützliche rekombinante il4 antikörper
DE59302386D1 (de) Verwendung von polykondensaten und neue polykondensate
ATA209789A (de) Behandlung von zementpulver
DK90089A (da) Hudbehandlingspraeparat
DE69033636D1 (de) Verwendung von 4-Acyloxychinolin-Derivate als Insektizide und Akarizide
DE68909432T2 (de) Direkte Fixierung von geflochtenen Strukturen.
DE69734296D1 (de) Neue dikaffeoylchinasäurederivate und deren verwendung zur behandlung von hepatitis b
DE3850433D1 (de) Allergiebehandlung und Zusammensetzung dafür.
DE3885913T2 (de) Aufbereitung von Alkoxysilanen.
DE69017825D1 (de) Heilverfahren von Lebererkrankungen mit Verwendung von Pyrrol-Chinolin-Chinone-Triester und neue Pyrrol-Chinolin-Chinone-Triester.
DE68911776D1 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
BR8903812A (pt) Transitor bipolar e metodo de formacao do mesmo
DE69325141D1 (de) Behandlung von lignozellulosehaltigen Materialien
DE68923219T2 (de) Behandlung von Abfällen.
DK507185A (da) Fremgangsmaade til inaktivering af human tumor leukaemi virus iii
DE69028631D1 (de) Behandlung von fasermaterialien
ATE142503T1 (de) Arzneimittelzubereitung bei der behandlung von tonsillitis
DE68908445T2 (de) Mittel zur Behandlung von Lebererkrankungen.
DE59003265D1 (de) Verwendung von nor-verapamil und nor-gallopamil als antiarteriosklerotica.
DE794791T1 (de) Neue therapeutische verwendung von superoxid-dismutasen
DE3869232D1 (de) Abkoemmlinge von bornan-3-spiro-l'-cyclopentan und diese enthaltende riechstoffzusammensetzungen.
DE69006964T2 (de) Behandlung von Hyperlipidemia mit 15-keto-Prostaglandin-Verbindungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee